HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keizo Sugimachi Selected Research

Therapeutics

7/2023Hypothyroidism With ACTH Deficiency During Pembrolizumab Therapy for Lung Cancer: Case Report and Literature Review.
1/2017[Analysis of Advanced or Postoperative Recurrent Non-small Lung Cancer Cases Treated with Nivolumab].
4/2005Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
5/2004Propranolol alone may not be acceptable to prevent first esophageal variceal bleeding in Japanese cirrhotic patients: randomized controlled trial.
11/2002Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat.
11/2002Role of dihydropyrimidine dehydrogenase activity in patients with esophageal cancer.
9/2002Results of endotoxin absorption after a subtotal resection of the small intestine and a right hemicolectomy for severe superior mesenteric ischemia.
3/2002Therapeutic strategy of emergency surgery for colon cancer in 71 patients over 70 years of age in Japan.
3/2002Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.
3/2002Significance of SIRS score in therapeutic strategy for acute appendicitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keizo Sugimachi Research Topics

Disease

40Neoplasms (Cancer)
07/2023 - 08/2000
14Carcinoma (Carcinomatosis)
09/2003 - 01/2002
13Hepatocellular Carcinoma (Hepatoma)
04/2007 - 01/2002
9Stomach Neoplasms (Stomach Cancer)
05/2004 - 01/2002
8Lymphatic Metastasis
05/2004 - 08/2000
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2003 - 03/2002
6Breast Neoplasms (Breast Cancer)
04/2005 - 01/2002
6Hemorrhage
05/2004 - 01/2002
6Carcinogenesis
03/2003 - 01/2002
5Neoplasm Metastasis (Metastasis)
09/2003 - 01/2002
5Liver Diseases (Liver Disease)
08/2002 - 01/2002
4Esophageal and Gastric Varices (Esophageal Varices)
05/2004 - 01/2002
4Fibrosis (Cirrhosis)
05/2004 - 01/2002
4Cholangiocarcinoma
01/2004 - 01/2002
3Adenocarcinoma
01/2017 - 05/2002
3Ischemia
09/2003 - 01/2002
3Esophageal Squamous Cell Carcinoma
03/2003 - 01/2002
3Esophageal Neoplasms (Esophageal Cancer)
12/2002 - 11/2002
3Hyperthermia
11/2002 - 01/2002
3Septic Shock (Toxic Shock Syndrome)
09/2002 - 01/2002
3Acute Liver Failure (Fulminant Hepatic Failure)
03/2002 - 01/2002
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2002 - 01/2002
2Lung Neoplasms (Lung Cancer)
07/2023 - 01/2017
2Pathologic Constriction (Stenosis)
03/2016 - 05/2002
2Reperfusion Injury
05/2006 - 09/2003
2End Stage Liver Disease
07/2005 - 01/2002
2Colorectal Neoplasms (Colorectal Cancer)
01/2005 - 10/2003
2Liver Failure
05/2004 - 01/2003
2Adenocarcinoma of Lung
01/2004 - 01/2002
2Infections
05/2003 - 01/2002
2Hyperplasia
06/2002 - 06/2002
2Portal Hypertension
05/2002 - 01/2002
2Rectal Neoplasms (Rectal Cancer)
01/2002 - 01/2002
1Hypothyroidism
07/2023
1Fatigue
07/2023
1Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2017

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
07/2003 - 01/2002
6Messenger RNA (mRNA)IBA
07/2003 - 02/2002
4Matrix Metalloproteinases (MMPs)IBA
01/2004 - 01/2002
4Cadherins (E-Cadherin)IBA
07/2003 - 01/2002
3polyurethane foamIBA
04/2007 - 01/2002
3UracilIBA
04/2005 - 01/2003
3TegafurIBA
04/2005 - 01/2003
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2005 - 01/2002
3Indicators and Reagents (Reagents)IBA
03/2003 - 03/2002
3DNA (Deoxyribonucleic Acid)IBA
11/2002 - 01/2002
3Thrombospondin 1IBA
05/2002 - 01/2002
3Monoclonal AntibodiesIBA
04/2002 - 01/2002
2Anti-Bacterial Agents (Antibiotics)IBA
03/2016 - 03/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2006 - 01/2002
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2005 - 03/2003
2TamoxifenFDA LinkGeneric
04/2005 - 01/2003
2Fluorouracil (Carac)FDA LinkGeneric
04/2005 - 11/2002
2Cisplatin (Platino)FDA LinkGeneric
09/2003 - 01/2002
2AntioxidantsIBA
09/2003 - 11/2002
2C-Reactive ProteinIBA
03/2003 - 01/2002
2doxifluridineIBA
03/2003 - 03/2002
2AngiopoietinsIBA
03/2003 - 04/2002
2Conjugated Linoleic AcidsIBA
12/2002 - 12/2002
2RNA (Ribonucleic Acid)IBA
12/2002 - 01/2002
2Dihydrotachysterol (AT 10)IBA
12/2002 - 01/2002
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2002 - 05/2002
2beta CateninIBA
12/2002 - 03/2002
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2002 - 11/2002
2EndotoxinsIBA
09/2002 - 03/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2002 - 05/2002
2Proliferating Cell Nuclear Antigen (PCNA)IBA
04/2002 - 01/2002
2LigandsIBA
04/2002 - 01/2002
2Transforming Growth Factor beta (TGF-beta)IBA
02/2002 - 01/2002
2Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2002 - 01/2002
2Hematoxylin (Haematoxylon)IBA
01/2002 - 01/2002
2Eosine Yellowish-(YS) (Eosin)IBA
01/2002 - 01/2002
1Adrenocorticotropic Hormone (ACTH)FDA Link
07/2023
1pembrolizumabIBA
07/2023
1Thyroxine (Levothyroxine)FDA LinkGeneric
07/2023
1Immune Checkpoint InhibitorsIBA
07/2023
1Isolated ACTH DeficiencyIBA
07/2023
1Ointments (Pastes)IBA
01/2017
1NivolumabIBA
01/2017
1SteroidsIBA
01/2017
1Anaplastic Lymphoma KinaseIBA
01/2017

Therapy/Procedure

14Therapeutics
07/2023 - 08/2000
8Drug Therapy (Chemotherapy)
07/2023 - 01/2002
8Liver Transplantation
05/2006 - 01/2002
5Splenectomy
09/2003 - 01/2002
4Lymph Node Excision (Lymph Node Dissection)
05/2004 - 08/2000
4Sclerotherapy
05/2004 - 01/2002
4Adjuvant Chemotherapy
10/2003 - 01/2003
3Esophagectomy
09/2003 - 01/2002
3Radiotherapy
05/2003 - 01/2002
2Stents
03/2016 - 02/2003
2Artificial Liver (Bioartificial Liver)
04/2007 - 01/2003
2Gastrectomy
05/2004 - 04/2002
2Segmental Mastectomy (Lumpectomy)
05/2004 - 06/2002
2Palliative Care (Palliative Therapy)
05/2003 - 01/2002
2Hepatectomy
05/2003 - 01/2002
2Laparotomy
04/2003 - 03/2003
2Transplantation
12/2002 - 03/2002
2Prostheses and Implants (Prosthesis)
11/2002 - 01/2002
1Immunotherapy
01/2017